Showing results (311-320 of 356) with videos related to
Sort By:
Pageof 36
Journal of Crohn'S & Colitis|December 12, 2018
Lack of the pH-sensing Receptor TDAG8 [GPR65] in Macrophages Plays a Detrimental Role in Murine Models of Inflammatory Bowel DiseaseIrina Tcymbarevich, Shola M Richards, Giancarlo Russo, et al.Mucosal Immunology|February 12, 2019
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitisAnnika Wyss, Tina Raselli, Nathan Perkins, et al.Journal of Crohn'S & Colitis|August 31, 2018
Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to FibrogenesisSenta Hutter, Wouter T van Haaften, Anouk Hünerwadel, et al.Plos One|March 13, 2018
Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patientsSabine Buhner, Hannes Hahne, Kerstin Hartwig, et al.Cell Reports. Medicine|July 16, 2025
Endoscopic healing in pediatric IBD perpetuates a persistent signature defined by Th17 cells with molecular and microbial drivers of diseaseKolja Siebert, Tim Faro, Nikolai Köhler, et al.Microbiome|April 2, 2023
Diet prevents the expansion of segmented filamentous bacteria and ileo-colonic inflammation in a model of Crohn's diseaseAmira Metwaly, Jelena Jovic, Nadine Waldschmitt, et al.Microbiome|August 4, 2018
The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolismSarah Just, Stanislas Mondot, Josef Ecker, et al.Inflammatory Bowel Diseases|April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort StudyStephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.Archives of Toxicology|May 28, 2024
Controversy on health-based guidance values for bisphenol A-the need of criteria for studies that serve as a basis for risk assessmentMarcel Leist, Andrea Buettner, Patrick Diel, et al.Alimentary Pharmacology & Therapeutics|October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.Pageof 36